Abstract
The misfolding, aggregation and accumulation of proteins in the brain, represents a common feature of diverse neurodegenerative diseases among which Alzheimers disease (AD). Important therapeutic strategies for this pathology aim at inhibiting the aggregation of misfolded amyloid β (Aβ) peptides into different species, particularly intermediate oligomeric assemblies, which are believed to be the most neurotoxic species. Here we review the structural data present in the literature, with the purpose to supply useful information for the rational design of new potential molecules able to target Aβ peptides and fibrils. In particular, structural information concerning the different Aβ peptides assemblies, their supramolecular organization, their interaction with cations, biological membranes and known ligands are reported.
Keywords: neurodegenerative disease, biological membrane, heart disease, intermediate oligomeric assemblies, aggregates, β-amyloid, Aβ oligomers, Aβ fibrils, Aβ peptide structural features, Alzheimers's disease
Current Bioactive Compounds
Title: Aβ Monomers, Oligomers and Fibrils: Structural Features
Volume: 7 Issue: 3
Author(s): Cristina Airoldi, Erika Sironi, Barbara La Ferla, Francisco Cardona and Francesco Nicotra
Affiliation:
Keywords: neurodegenerative disease, biological membrane, heart disease, intermediate oligomeric assemblies, aggregates, β-amyloid, Aβ oligomers, Aβ fibrils, Aβ peptide structural features, Alzheimers's disease
Abstract: The misfolding, aggregation and accumulation of proteins in the brain, represents a common feature of diverse neurodegenerative diseases among which Alzheimers disease (AD). Important therapeutic strategies for this pathology aim at inhibiting the aggregation of misfolded amyloid β (Aβ) peptides into different species, particularly intermediate oligomeric assemblies, which are believed to be the most neurotoxic species. Here we review the structural data present in the literature, with the purpose to supply useful information for the rational design of new potential molecules able to target Aβ peptides and fibrils. In particular, structural information concerning the different Aβ peptides assemblies, their supramolecular organization, their interaction with cations, biological membranes and known ligands are reported.
Export Options
About this article
Cite this article as:
Airoldi Cristina, Sironi Erika, La Ferla Barbara, Cardona Francisco and Nicotra Francesco, Aβ Monomers, Oligomers and Fibrils: Structural Features, Current Bioactive Compounds 2011; 7 (3) . https://dx.doi.org/10.2174/157340711796817896
DOI https://dx.doi.org/10.2174/157340711796817896 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Conditional Cardiac Overexpression of S100A6 Attenuates Myocyte Hypertrophy and Apoptosis Following Myocardial Infarction
Current Pharmaceutical Design Analysis of Carotid Ultrasound Images for the Assessment of Stroke Risk Using Level Set Method
Current Medical Imaging Pivotal Role of Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 in Inflammatory Pulmonary Diseases
Current Protein & Peptide Science Metabolic Syndrome and Asthma
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Mesenchymal Stem Cells as Mediators of Neural Differentiation
Current Stem Cell Research & Therapy Bridging the Gap: The Potential Role of Corticosteroid Binding Globulin in Cardiac Steroid Facilitation
Current Drug Targets Relationship Between Body Mass Index and Reproduction
Current Women`s Health Reviews Current Status of Hormone Replacement Therapy in Post Menopausal Women
Current Drug Therapy Lipoprotein(a): Medical Treatment Options for an Elusive Molecule
Current Pharmaceutical Design Nuclear Magnetic Resonance Spectroscopy and Genetic Disorders
Current Medicinal Chemistry The Utility of Emerging Biomarkers and Imaging for Assessment of Cardiovascular Risk
Current Vascular Pharmacology Metabolic Syndrome, Thyroid Function and Autoimmunity - The PORMETS Study
Endocrine, Metabolic & Immune Disorders - Drug Targets Diabetic Heart and the Cardiovascular Surgeon
Cardiovascular & Hematological Disorders-Drug Targets Role of Vitamins in Human Health and Nutrition: Sources and Morbidity
Current Nutrition & Food Science Individual Triptan Selection in Migraine Attack Therapy
Recent Patents on CNS Drug Discovery (Discontinued) Comparative Effect of Telmisartan vs Lisinopril on Blood Pressure in Patients of Metabolic Syndrome
Endocrine, Metabolic & Immune Disorders - Drug Targets Can Erythrocyte Catalase Regulate Blood Pressure?
Cardiovascular & Hematological Agents in Medicinal Chemistry The Antidiabetic Effects of The Bioactive Flavonoid (Kaempferol-3-O-β-D-6{P- Coumaroyl} Glucopyranoside) Isolated From Allium cepa
Recent Patents on Anti-Infective Drug Discovery Resveratrol Targets in Inflammation
Endocrine, Metabolic & Immune Disorders - Drug Targets Obesity, Diabetes and Cardiovascular Diseases in India: Public Health Challenges
Current Diabetes Reviews